Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Mulder

Showing results (261-270 of 429) with videos related to

Pageof 43
Sort By:
Pharmacological Research|September 5, 2002
Prognostic factors for the clinical effectiveness of fluconazole in the treatment of oral candidiasis in HIV-1-infected individualsC H W Koks, K M L Crommentuyn, R A A Mathôt, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 20, 2004
Drug-drug interaction between itraconazole and the antiretroviral drug lopinavir/ritonavir in an HIV-1-infected patient with disseminated histoplasmosisKristel M L Crommentuyn, Jan W Mulder, Rolf W Sparidans, et al.
Journal of Chromatography. B, Biomedical Sciences and Applications|December 30, 1998
Simultaneous quantitative determination of the HIV protease inhibitors amprenavir, indinavir, nelfinavir, ritonavir and saquinavir in human plasma by ion-pair high-performance liquid chromatography with ultraviolet detectionR P van Heeswijk, R M Hoetelmans, R Harms, et al.
Clinical Pharmacokinetics|July 21, 2005
Population pharmacokinetics of efavirenz in an unselected cohort of HIV-1-infected individualsBregt S Kappelhoff, Alwin D R Huitema, Zeynep Yalvaç, et al.
AIDS (London, England)|May 1, 1989
Prevalence of HIV-1 antibody among groups of patients and healthy subjects from a rural and urban population in the Mwanza region, TanzaniaW M Dolmans, A M van Loon, R van den Akker, et al.
Antiviral Therapy|March 7, 2002
Combination of protease inhibitors for the treatment of HIV-1-infected patients: a review of pharmacokinetics and clinical experienceR P van Heeswijk, A Veldkamp, J W Mulder, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|June 1, 1997
Penetration of 3'-amino-3'-deoxythymidine, a cytotoxic metabolite of zidovudine, into the cerebrospinal fluid of HIV-1-infected patientsR M Hoetelmans, C L Kraaijeveld, P L Meenhorst, et al.
The Journal of Infectious Diseases|September 1, 1993
Viral phenotype and T cell reactivity in human immunodeficiency virus type 1-infected asymptomatic men treated with zidovudineM Koot, P T Schellekens, J W Mulder, et al.
Antiviral Therapy|July 1, 1997
Clinically relevant drug interactions with antiretroviral agentsD M Burger, R M Hoetelmans, P P Koopmans, et al.
The Journal of Infectious Diseases|March 1, 1992
Dehydroepiandrosterone as predictor for progression to AIDS in asymptomatic human immunodeficiency virus-infected menJ W Mulder, P H Frissen, P Krijnen, et al.
Pageof 43

Showing results (261-270 of 429) with videos related to

Sort By:
Pageof 43
Pharmacological Research|September 5, 2002
Prognostic factors for the clinical effectiveness of fluconazole in the treatment of oral candidiasis in HIV-1-infected individualsC H W Koks, K M L Crommentuyn, R A A Mathôt, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 20, 2004
Drug-drug interaction between itraconazole and the antiretroviral drug lopinavir/ritonavir in an HIV-1-infected patient with disseminated histoplasmosisKristel M L Crommentuyn, Jan W Mulder, Rolf W Sparidans, et al.
Journal of Chromatography. B, Biomedical Sciences and Applications|December 30, 1998
Simultaneous quantitative determination of the HIV protease inhibitors amprenavir, indinavir, nelfinavir, ritonavir and saquinavir in human plasma by ion-pair high-performance liquid chromatography with ultraviolet detectionR P van Heeswijk, R M Hoetelmans, R Harms, et al.
Clinical Pharmacokinetics|July 21, 2005
Population pharmacokinetics of efavirenz in an unselected cohort of HIV-1-infected individualsBregt S Kappelhoff, Alwin D R Huitema, Zeynep Yalvaç, et al.
AIDS (London, England)|May 1, 1989
Prevalence of HIV-1 antibody among groups of patients and healthy subjects from a rural and urban population in the Mwanza region, TanzaniaW M Dolmans, A M van Loon, R van den Akker, et al.
Antiviral Therapy|March 7, 2002
Combination of protease inhibitors for the treatment of HIV-1-infected patients: a review of pharmacokinetics and clinical experienceR P van Heeswijk, A Veldkamp, J W Mulder, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|June 1, 1997
Penetration of 3'-amino-3'-deoxythymidine, a cytotoxic metabolite of zidovudine, into the cerebrospinal fluid of HIV-1-infected patientsR M Hoetelmans, C L Kraaijeveld, P L Meenhorst, et al.
The Journal of Infectious Diseases|September 1, 1993
Viral phenotype and T cell reactivity in human immunodeficiency virus type 1-infected asymptomatic men treated with zidovudineM Koot, P T Schellekens, J W Mulder, et al.
Antiviral Therapy|July 1, 1997
Clinically relevant drug interactions with antiretroviral agentsD M Burger, R M Hoetelmans, P P Koopmans, et al.
The Journal of Infectious Diseases|March 1, 1992
Dehydroepiandrosterone as predictor for progression to AIDS in asymptomatic human immunodeficiency virus-infected menJ W Mulder, P H Frissen, P Krijnen, et al.
Pageof 43